Strides Pharma's Board has strengthened its internal policy on handling price-sensitive company information.

This update aims for prompt and uniform disclosure of important news, boosting transparency for investors.

The Chief Financial Officer is now designated to manage all information dissemination, including responding to market rumors.

The revised policy details how sensitive data can be shared for legitimate business needs on a "need-to-know" basis, with a new requirement to maintain a digital record of such disclosures.

This enhances corporate governance and investor trust.